Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy TG Therapeutics stock

Learn how to easily invest in TG Therapeutics stock.

TG Therapeutics Inc is a biotechnology business based in the US. TG Therapeutics shares (TGTX) are listed on the NASDAQ and all prices are listed in US Dollars. TG Therapeutics employs 173 staff and has a trailing 12-month revenue of around $7 million.

How to buy shares in TG Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – TGTX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

TG Therapeutics stock price (NASDAQ: TGTX)

Use our graph to track the performance of TGTX stocks over time.

TG Therapeutics shares at a glance

Information last updated 2022-09-25.
Latest market close$6.00
52-week range$3.48 - $35.94
50-day moving average $6.81
200-day moving average $8.98
Wall St. target price$16.88
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.46

Buy TG Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 8 of 8
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy TG Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

TG Therapeutics price performance over time

Historical closes compared with the close of $6 from 2022-09-27

1 week (2022-09-21) -4.61%
1 month (2022-08-26) -11.24%
3 months (2022-06-28) 47.78%
6 months (2022-03-28) -39.58%
1 year (2021-09-28) -81.84%
2 years (2020-09-28) -76.50%
3 years (2019-09-27) 6.19%
5 years (2017-09-28) 11.8

TG Therapeutics financials

Revenue TTM $7 million
Gross profit TTM $5.9 million
Return on assets TTM -48.41%
Return on equity TTM -112.66%
Profit margin 0%
Book value $0.96
Market capitalisation $833.9 million

TTM: trailing 12 months

TG Therapeutics share dividends

We're not expecting TG Therapeutics to pay a dividend over the next 12 months.

Have TG Therapeutics's shares ever split?

TG Therapeutics's shares were split on a 100:5625 basis on 29 April 2012. So if you had owned 5625 shares the day before before the split, the next day you'd have owned 100 shares. This wouldn't directly have changed the overall worth of your TG Therapeutics shares – just the quantity. However, indirectly, the new 5525% higher share price could have impacted the market appetite for TG Therapeutics shares which in turn could have impacted TG Therapeutics's share price.

TG Therapeutics share price volatility

Over the last 12 months, TG Therapeutics's shares have ranged in value from as little as $3.48 up to $35.94. A popular way to gauge a stock's volatility is its "beta".

TGTX.US volatility(beta: 2.18)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while TG Therapeutics's is 2.1806. This would suggest that TG Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.

TG Therapeutics overview

TG Therapeutics, Inc. , a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbralisib, an oral inhibitor of PI3K-delta and CK1-epsilon for the treatment of CLL, marginal zone lymphoma, and follicular lymphoma. The company also develops Cosibelimab, a human monoclonal antibody of IgG1 subtype that binds to programmed death-ligand 1 (PD-L1) and blocks its interactions with PD-1 and B7. 1 receptors; TG-1701 is an orally available and covalently-bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK compared to ibrutinib in in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. In addition, it has various licensed preclinical programs for BET, interleukin-1 receptor associated kinase-4, and GITR; and collaboration agreements with Checkpoint Therapeutics, Inc. , Jiangsu Hengrui Medicine Co.

Frequently asked questions

What percentage of TG Therapeutics is owned by insiders or institutions?
Currently 8.259% of TG Therapeutics shares are held by insiders and 74.386% by institutions.
How many people work for TG Therapeutics?
Latest data suggests 173 work at TG Therapeutics.
When does the fiscal year end for TG Therapeutics?
TG Therapeutics's fiscal year ends in December.
Where is TG Therapeutics based?
TG Therapeutics's address is: 2 Gansevoort Street, New York, NY, United States, 10014
What is TG Therapeutics's ISIN number?
TG Therapeutics's international securities identification number is: US88322Q1085
What is TG Therapeutics's CUSIP number?
TG Therapeutics's Committee on Uniform Securities Identification Procedures number is: 048785109

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site